Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
71,508,907
-
Share change
-
+24,396,721
-
Total reported value
-
$150,883,720
-
Put/Call ratio
-
26%
-
Price per share
-
$2.11
-
Number of holders
-
105
-
Value change
-
+$51,399,890
-
Number of buys
-
69
-
Number of sells
-
20
Institutional Holders of IDERA PHARMACEUTICALS INC - COM NEW (IDRA) as of Q4 2017
As of 31 Dec 2017,
IDERA PHARMACEUTICALS INC - COM NEW (IDRA) was held by
105 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
71,508,907 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, BlackRock Inc., Vanguard Group Inc, MILLENNIUM MANAGEMENT LLC, NATIXIS, FMR LLC, JPMORGAN CHASE & CO, Bain Capital Public Equity Management, LLC, STATE STREET CORP, and Broadfin Capital, LLC.
This page lists
105
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.